Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MullenLowe China, formerly known as Lowe China, is a leading integrated marketing communications agency and a key part of the global MullenLowe Group. While primarily an advertising and branding firm, the company maintains a significant healthcare division, MullenLowe Health, which provides specialized marketing, branding, and strategic communications services to pharmaceutical and life science companies in the Chinese market. The agency focuses on brand building, digital transformation, and consumer engagement for major global and domestic healthcare brands. It operates as a subsidiary of the Interpublic Group (IPG), leveraging global resources to navigate the complex regulatory and commercial landscape of the Chinese healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lowe China.